The exciting and magical journey of components from compound formulae to where they fight

Abstract

With its long-term empirical clinical practice and increasing number of health benefits reported, Chinese Materia Medica (CMM) is gaining increasing global acceptance. Importantly, the identification of chemical constituents in vitro and exposed forms in vivo is a prerequisite for understanding how CMM formulae prevent and treat diseases. This review systematically summarizes the exciting and magical journey of CMM components from compound formulae to where they fight, the possible structural transformation of CMM components in vitro and in vivo, and their pharmacological contribution. When a decoction is prepared, significant chemical reactions are observed, including degradation and production of polymers and self-assembling supramolecules, leading to the construction of a component library with diverse decoction structures. After ingestion, compounds pass through the intestinal and blood-brain barriers and undergo a more wonderful journey involving the gut microbiota, microbial enzymes, and endogenous drug-metabolizing enzymes (mainly liver enzymes). At this stage, they are modified and assembled into novel and complex compounds, such as newly generated metabolites, conjugates, and self-assembling superamolecules. This review might provide a strategic orientation to explore the active compounds of CMM formulae in vivo.

Keywords

Chinese Material Medica / Formulae / Gut microbiota / Metabolites / Prototype components / Self-assembling supramolecule

References

[[1]] Cheung F.TCM: Made in China. Nature. 2011;480(7378):S82-S83.

[[2]] Jiang M, Lu C, Zhang C, et al.Syndrome differentiation in modern research of traditional Chinese medicine. [J] Ethnopharmacol. 2012;140(3):634-642.

[[3]] Cheng F, Wang X, Song W, et al.Biologic basis of TCM syndromes and the standardization of syndrome classification. [J] Traditional Chinese Med Sci. 2014;1(2):92-97.

[[4]] World Health Organization. WHO international standard terminologies on traditional medicine in the Western Pacific Region. Manila: WHO Regional Office for the Western Pacific2007.

[[5]] Jin Y, Qu C, Tang Y, et al. Herb pairs containing angelicae sinensis radix (Danggui): a review of bio-active constituents and compatibility effects. J Ethnopharmacol. 2016;181:158-171.

[[6]] Wei G, Zheng X.A survey of the studies on compatible law of ingredients in Chinese herbal prescriptions. [J] Tradit Chin Med. 2008;28(3):223-227.

[[7]] Ma Y, Chen M, Guo Y, et al.Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary. APMIS. 2019;127(5):372-384.

[[8]] Ni L, Yuan W, Chen L, et al. Combating COVID-19 with integrated traditional Chinese and western medicine in China. Acta Pharm Sin B. 2020;10(7):1149-1162.

[[9]] Runfeng L, Yunlong H, Jicheng H, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. 2020;156:104761.

[[10]] Yang Y, Sun M, Yao W, et al.Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib. [J] ImmunoTher Cancer. 2020;8(1):e000317.

[[11]] Qi S, Li X, Dong Q, et al. Chinese herbal medicine (Xiaoaiping) injections for chemotherapy-induced thrombocytopenia: a randomized, controlled, multicenter clinical trial. J Altern Complement Med. 2019;25(6):648-655.

[[12]] Tu Y. Artemisinin-A gift from traditional Chinese medicine to the world (Nobel Lecture). Angew Chem Int Ed Engl. 2016;55(35):10210-10226.

[[13]] Kong WJ, Vernieri C, Foiani M, et al. Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders. Pharmacol Ther. 2020;209:107496.

[[14]] Ding J, Zhang J, Xiao M, et al.The theory and practice of CMM formulae treating disease by targeting intestinal flora. Modernization Traditional Chinese Med Materia Medica-World Sci Technol. 2018;20(2):157-162.

[[15]] Li X, Shan C, Wu Z, et al.Emodin alleviated pulmonary inflammation in rats with LPS-induced acute lung injury through inhibiting the mTOR/HIF-1α/VEGF signaling pathway. Inflamm Res. 2020;69(4):365-373.

[[16]] Yan T, Yan N, Wang P, et al. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta pharmaceutica Sinica B. 2020;10(1):3-18.

[[17]] Zhou ZY, Zhao WR, Zhang J, et al.Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics. Biomed Pharmacother. 2019;118:109362.

[[18]] Lu G, Dong Z, Wang Q, et al. Toxicity assessment of nine types of decoction pieces from the daughter root of Aconitum carmichaeli (Fuzi) based on the chemical analysis of their diester diterpenoid alkaloids. Planta Med. 2010;76(8):825-830.

[[19]] Pang H, Wang J, Tang Y, et al.Comparative analysis of the main bioactive components of Xin-Sheng-Hua granule and its single herbs by ultrahigh performance liquid chromatography with tandem mass spectrometry. [J] Sep Sci. 2016;39(21):4096-4106.

[[20]] Wu B, Cui W.Current situation and prospect of trace elements in traditional Chinese medicine. Chinese Traditional Herbal Drugs. 1986;17(4):38-42.

[[21]] Cao Z.New thinking about study of pharmacodynamic material basis and functional mechanism in Chinese Materia Medica——Study on the relation between morphology and biological activity of chemical species in Chinese Materia Medica. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai. 2000;14(1):36-40.

[[22]] Liu Y, He X, Liu X, et al.Synthesis of baicalin-copper and baicalin-aluminium complex and its bioactivity. China [J] Chinese Materia Medica. 2012;37(9):1296-1302.

[[23]] Mei X, Xu D, Xu S, et al. Novel role of Zn(II)-curcumin in enhancing cell proliferation and adjusting proinflammatory cytokine-mediated oxidative damage of ethanol-induced acute gastric ulcers. Chem Biol Interact. 2012;197(1):31-39.

[[24]] Chen ZF, Shi YF, Liu YC, et al.TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA. Inorg Chem. 2012;51(4):1998-2009.

[[25]] Cao ZY, Chen XZ, Chang ET, et al.Effective components of Chinese herbal compound decoction and Maillard reaction. Chin [J] Integr Med. 2009;15(3):224-228.

[[26]] Guo Y.Study on the relationship between Millard reaction and mechanism for processing Redix Rehmanniae. Ji’nan: Shandong University 2012.

[[27]] Liang L, Xu J, Zhou WW, et al.Integrating targeted and untargeted metabolomics to investigate the processing chemistry of polygoni multiflori radix. Front Pharmacol. 2018;9:934.

[[28]] Fay LB, Brevard H.Contribution of mass spectrometry to the study of the Maillard reaction in food. Mass Spectrom Rev. 2005;24(4):487-507.

[[29]] Langner E, Nunes FM, Pożarowski P, et al. Melanoidins isolated from heated potato fiber (Potex) affect human colon cancer cells growth via modulation of cell cycle and proliferation regulatory proteins. Food Chem Toxicol. 2013;57:246-255.

[[30]] Yang S, Fan W, Xu Y.Melanoidins from Chinese distilled spent grain: content, preliminary structure, antioxidant, and ACE-inhibitory activities in vitro. Foods (Basel, Switzerland). 2019;8(10):516.

[[31]] Yang S, Wang G, Ma ZF, et al.Dietary advanced glycation end products-induced cognitive impairment in aged ICR mice: protective role of quercetin. Mol Nutr Food Res. 2020;64(3):e1901019.

[[32]] Zhang Y, Yao Y, Shi X, et al.Combination of cell metabolomics and pharmacology: A novel strategy to investigate the neuroprotective effect of Zhi-zi-chi decoction. [J] Ethnopharmacol. 2019;236:302-315.

[[33]] Cui Y, Dong T, Tian J. Study on finding lead compounds with antidepressant activity in Zhi-Zi-Chi Decoction. The 10th National Young Pharmaceutical Workers Latest Scientific Research Achievements Exchange Meeting of Shihuida Cup in 2010. Changchun, Jilin,China 2010.

[[34]] Li KD, Yan K, Wang QS, et al.Antidepressant-like effects of dietary gardenia blue pigment derived from genipin and tyrosine. Food Funct. 2019;10(8):4533-4545.

[[35]] Touyama R, Takeda Y, Inoue K, et al.Studies on the blue pigments produced from genipin and methylamine. I. Structures of the brownish-red pigments, intermediates leading to the blue pigments. Chem Pharm Bull (Tokyo). 1994;42:668-673.

[[36]] Touyama R, Inoue K, Takeda Y, et al.Studies on the blue pigments produced from genipin and methylamine. II. On the formation mechanisms of brownish-red intermediates leading to the blue pigment formation. Chem Pharm Bull (Tokyo). 1994;42:1571-1578.

[[37]] Chen J, Zhao X, Zhang B, et al. Coloring/Cross-linking properties of natural irioids with protein fibers (II)-forming rules and mechanism of methylamine and protein fibers dyed by four natural iridoids. China Leather. 2010;39(17):13-17.

[[38]] Wang J, Zhang B, He D, et al. Coloring/Cross-linking properties of natural irioids with protein fibers (I)-preparation of four natural iridoids and their dyeing/cross-linking (tanning) property to hide power. China Leather.2010;39(15):4-8 + 12.

[[39]] Hodge JE.Dehydrated foods, chemistry of browning reactions in model systems. [J] Agric Food Chem. 1953;1(15):928-943.

[[40]] Silván JM, Assar SH, Srey C, et al.Control of the maillard reaction by ferulic acid. Food Chem. 2011;128(1):208-213.

[[41]] Yu H, Seow YX, Ong PKC, et al.Effects of high-intensity ultrasound on Maillard reaction in a model system of d-xylose and l-lysine. Ultrason Sonochem. 2017;34:154-163.

[[42]] Mohsin GF, Schmitt FJ, Kanzler C, et al. Structural characterization of melanoidin formed from d-glucose and l-alanine at different temperatures applying FTIR, NMR, EPR, and MALDI-ToF-MS. Food Chem. 2018;245:761-767.

[[43]] Kanzler C, Haase PT.Melanoidins formed by heterocyclic Maillard reaction intermediates via aldol reaction and Michael addition. [J] Agric Food Chem. 2020;68(1):332-339.

[[44]] Rodríguez A, Lema P, Bessio MI, et al.Isolation and characterization of melanoidins from dulce de leche, a confectionary dairy product. Molecules (Basel, Switzerland). 2019;24(22):4163.

[[45]] Zhuang Y, Yan J, Zhu W, et al.Can the aggregation be a new approach for understanding the mechanism of traditional Chinese medicine? [J] Ethnopharmacol. 2008;117(2):378-384.

[[46]] Shoichet BK.Screening in a spirit haunted world. Drug Discov Today. 2006;11(13-14):607-615.

[[47]] Feng BY, Shoichet BK.A detergent-based assay for the detection of promiscuous inhibitors. Nat Protoc. 2006;1(2):550-553.

[[48]] McGovern SL, Caselli E, Grigorieff N, et al. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. [J] Med Chem. 2002;45(8):1712-1722.

[[49]] Zhou J, Gao G, Chu Q, et al.Chromatographic isolation of nanoparticles from Ma-Xing-Shi-Gan-Tang decoction and their characterization. [J] Ethnopharmacol. 2014;151(3):1116-1123.

[[50]] Zhou J, Zhang J, Gao G, et al.Boiling licorice produces self-assembled protein nanoparticles: a novel source of bioactive nanomaterials. [J] Agric Food Chem. 2019;67(33):9354-9361.

[[51]] Weng Q, Cai X, Zhang F, et al.Fabrication of self-assembled Radix Pseudostellariae protein nanoparticles and the entrapment of curcumin. Food Chem. 2019;274:796-802.

[[52]] Li T, Wang P, Guo W, et al.Natural berberine-based Chinese herb medicine assembled nanostructures with modified antibacterial application. ACS Nano. 2019;13(6):6770-6781.

[[53]] Zheng J, Fan R, Wu H, et al.Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation. Nat Commun. 2019;10(1):1604.

[[54]] Chen F, Wen Q, Jiang J, et al.Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs? [J] Ethnopharmacol. 2016;179:253-264.

[[55]] Liu T, Tian X, Li Z, et al. Metabolic profiling of Gegenqinlian decoction in rat plasma, urine, bile and feces after oral administration by ultra high performance liquid chromatography coupled with Fourier transform ion cyclotron resonance mass spectrometry. J Chromatogr B. 2018;1079:69-84.

[[56]] Xu J, Lian F, Zhao L, et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J. 2015;9(3):552-562.

[[57]] Kumar S. Colon targeted drug delivery systems-A review. Russian J Biopharmaceuticals. 2011;3(4):25-33.

[[58]] Eckburg PB, Bik EM, Bernstein CN, et al.Diversity of the human intestinal microbial flora. Science (New York, NY). 2005;308(5728):1635-1638.

[[59]] Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science (New York, NY). 2017;356(6344):eaag2770.

[[60]] Feng R, Shou JW, Zhao ZX, et al.Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep. 2015;5:12155.

[[61]] Zhang M, Peng CS, Li XB.In vivo and in vitro metabolites from the main diester and monoester diterpenoid alkaloids in a traditional Chinese herb, the aconitum species. Evid Based Complement Alternat Med. 2015;2015:252434.

[[62]] Jiao L, Li Y, Zhang Y, et al.Degradation kinetics of 6‴-p-Coumaroylspinosin and identification of its metabolites by rat intestinal flora. [J] Agric Food Chem. 2017;65(22):4449-4455.

[[63]] Wan JY, Zhang YZ, Yuan JB, et al.Biotransformation and metabolic profile of anemoside B4 with rat small and large intestine microflora by ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. Biomed Chromatogr. 2017;31(5):e3873.

[[64]] Zhao ZX, Fu J, Ma SR, et al.Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin. Theranostics. 2018;8(21):5945-5959.

[[65]] Matsumoto M, Ishige A, Yazawa Y, et al. Promotion of intestinal peristalsis by Bifidobacterium spp. capable of hydrolysing sennosides in mice. PLoS One.2012;7(2):e31700e317-e3170000-e.

[[66]] Espín JC, Larrosa M, García-Conesa MT, et al.Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. 2013;2013:270418.

[[67]] Espín JC, González-Barrio R, Cerdá B, et al.Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. [J] Agric Food Chem. 2007;55(25):10476-10485.

[[68]] Yang XW, Xing ZT, Cui JR, et al.Studies on the metabolism of cinobufagin and cinobufotalin by human intestinal bacteria. J Peking Univ (Health Sciences). 2001;33(3):199-204.

[[69]] Ding Y, Yan Y, Peng Y, et al.In vitro digestion under simulated saliva, gastric and small intestinal conditions and fermentation by human gut microbiota of polysaccharides from the fruits of Lycium barbarum. Int [J] Biol Macromol. 2019;125:751-760.

[[70]] Liu F, Zhang N, Li Z, et al.Chondroitin sulfate disaccharides modified the structure and function of the murine gut microbiome under healthy and stressed conditions. Sci Rep. 2017;7(1):6783.

[[71]] Meselhy MR, Kadota S, Tsubono K, et al.Shikometabolins A, B, C and D, novel dimeric naphthoquinone metabolites obtained from shikonin by human intestinal bacteria. Tetrahedron Lett. 1994;35(4):583-586.

[[72]] Zhang S, Zhao Y, Ohland C, et al. Microbiota facilitates the formation of the aminated metabolite of green tea polyphenol(-)-epigallocatechin-3-gallate which trap deleterious reactive endogenous metabolites. Free Radic Biol Med. 2019;131:332-344.

[[73]] Gao MX, Tang XY, Zhang FX, et al.Biotransformation and metabolic profile of Xian-Ling-Gu-Bao capsule, a traditional Chinese medicine prescription, with rat intestinal microflora by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry analysis. Biomed Chromatogr. 2018;32(4):e4160.

[[74]] Wang RF, Yuan M, Yang XB, et al.Intestinal bacterial transformation - a nonnegligible part of Chinese medicine research. [J] Asian Nat Prod Res. 2013;15(5):532-549.

[[75]] Wang X, Chang X, Luo X, et al.An integrated approach to characterize intestinal metabolites of four phenylethanoid glycosides and intestinal microbe-mediated antioxidant activity evaluation in vitro using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1, 1-Diphenyl-2-picrylhydrazyl-based assay. Front Pharmacol. 2019;10:826.

[[76]] Xu F, Li DP, Huang ZC, et al.Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MSn. [J] Pharm Biomed Anal. 2015;115:418-430.

[[77]] Cantarel BL, Lombard V, Henrissat B.Complex carbohydrate utilization by the healthy human microbiome. PLoS One. 2012;7(6):e28742.

[[78]] Xu J, Chen HB, Li SL.Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota. Med Res Rev. 2017;37(5):1140-1185.

[[79]] Xing J, Chen X, Zhong D.Absorption and enterohepatic circulation of baicalin in rats. Life Sci. 2005;78(2):140-146.

[[80]] Feng W, Ao H, Peng C, et al.Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 2019;142:176-191.

[[81]] Postler TS, Ghosh S.Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab. 2017;26(1):110-130.

[[82]] Liu J, Yue S, Yang Z, et al.Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. Pharmacol Res. 2018;134:40-50.

[[83]] Nicolas GR, Chang PV.Deciphering the chemical lexicon of host-gut microbiota interactions. Trends Pharmacol Sci. 2019;40(6):430-445.

[[84]] Tong X, Xu J, Lian F, et al.Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. mBio. 2018;9(3):e02392-17.

[[85]] Wang Z, Klipfell E, Bennett BJ, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57-63.

[[86]] Yu H, Geng WC, Zheng Z, et al.Facile fluorescence monitoring of gut microbial metabolite trimethylamine -oxide via molecular recognition of guanidinium-modified calixarene. Theranostics. 2019;9(16):4624-4632.

[[87]] Chhibber-Goel J, Singhal V, Parakh N, et al.The metabolite trimethylamine-N-Oxide is an emergent biomarker of human health. Curr Med Chem. 2017;24(36):3942-3953.

[[88]] Chen ML, Yi L, Zhang Y, et al. Resveratrol attenuates trimethylamine-N-Oxide (TMAO)-Induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio.2016;7(2):e02210-ee2215.

[[89]] Neinast MD, Jang C, Hui S, et al. Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab.2019;29(2):417-429.e4.

[[90]] Sivanand S, Vander Heiden MG.Emerging roles for branched-chain amino acid metabolism in cancer. Cancer Cell. 2020;37(2):147-156.

[[91]] Solon-Biet SM, Cogger VC, Pulpitel T, et al.Branched chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control. Nat Metab. 2019;1(5):532-545.

[[92]] Yue SJ, Liu J, Wang AT, et al.Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Am [J] Physiol Endocrinol Metab. 2018;316(1):E73-E85.

[[93]] Naccarato A, Gionfriddo E, Sindona G, et al.Development of a simple and rapid solid phase microextraction-gas chromatography-triple quadrupole mass spectrometry method for the analysis of dopamine, serotonin and norepinephrine in human urine. Anal Chim Acta. 2014;810:17-24.

[[94]] Shariatgorji M, Strittmatter N, Nilsson A, et al.Simultaneous imaging of multiple neurotransmitters and neuroactive substances in the brain by desorption electrospray ionization mass spectrometry. Neuroimage. 2016;136:129-138.

[[95]] Luan H, Wang X, Cai Z.Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders. Mass Spectrom Rev. 2019;38(1):22-33.

[[96]] Cheng D, Chang H, Ma S, et al.Tiansi liquid modulates gut microbiota composition and Tryptophan⁻Kynurenine metabolism in rats with hydrocortisone-induced depression. Molecules (Basel, Switzerland). 2018;23(11):2832.

[[97]] Wu D, Yang JJ, Yang F, et al.Analysis of alkaline and neutral volatile metabolites in feces by gas chromatography-tandem mass spectrometry. Chin [J] Anal Chem. 2017;45(6):837-843.

[[98]] Xu W, Chen D, Wang N, et al.Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal Chem. 2015;87(2):829-836.

[[99]] Yen S, Mcdonald JAK, Schroeter K, et al.Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. [J] Proteome Res. 2015;14(3):1472-1482.

[[100]] Hughes R, Kurth MJ, Mcgilligan V, et al.Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro. Nutr Cancer. 2008;60(2):259-266.

[[101]] Dou L, Jourde-Chiche N, Faure V, et al.The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. [J] Thromb Haemost. 2010;5(6):1302.

[[102]] Tao WW, Yu JG, Chen YY, et al.Incompatible mechanism of compatibility of Chinese medicines based on Qianjinzi and Gancao effect on intestinal flora/barrier system. China [J] Chinese Materia Medica. 2018;43(2):369-371.

[[103]] Yao C, Rotbart A, Ou J, et al.Modulation of colonic hydrogen sulfide production by diet and mesalazine utilizing a novel gas-profiling technology. Gut Microbes. 2018;9(6):510-522.

[[104]] Yu J, Liu Y, Guo J, et al.Health risk of Licorice-Yuanhua combination through induction of colonic H2S metabolism. [J] Ethnopharmacol. 2019;236:136-146.

[[105]] Kalantar-zadeh K, Berean K, Burgell R, et al. Intestinal gases: influence on gut disorders and the role of dietary manipulations. Nat Rev Gastroenterol Hepatol. 2019;16:1-15.

[[106]] Zhao M, Zhao L, Xiong X, et al. TMAVA, a metabolite of intestinal microbes, is increased in plasma from patients with liver steatosis, inhibits γ-butyrobetaine hydroxylase, and exacerbates fatty liver in mice. Gastroenterology. 2020;158(8):2266-81.e27.

[[107]] Gu S, Cao B, Sun R, et al.A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine. Mol Biosyst. 2015;11(2):463-474.

[[108]] Ridlon JM, Kang DJ, Hylemon PB.Bile salt biotransformations by human intestinal bacteria. [J] Lipid Res. 2006;47(2):241-259.

[[109]] Li T, Chiang JYL.Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 2014;66(4):948-983.

[[110]] Yajima M, Karaki SI, Tsuruta T, et al.Diversity of the intestinal microbiota differently affects non-neuronal and atropine-sensitive ileal contractile responses to short-chain fatty acids in mice. Biomed Res. 2016;37(5):319-328.

[[111]] Taormina VM, Unger AL, Schiksnis MR, et al.Branched-Chain fatty acids—An underexplored class of dairy-derived fatty acids. Nutrients. 2020;12(9):2875.

[[112]] Song Y, Wu MS, Tao G, et al.Feruloylated oligosaccharides and ferulic acid alter gut microbiome to alleviate diabetic syndrome. Food Res Int. 2020;137:109410.

[[113]] Clarke G, Stilling RM, Kennedy PJ, et al.Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28(8):1221-1238.

[[114]] Cryan JF, Dinan TG.Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701-712.

[[115]] Zheng X, Xie G, Zhao A, et al.The footprints of gut microbial-mammalian co-metabolism. [J] Proteome Res. 2011;10(12):5512-5522.

[[116]] Zhong LJ, Xie ZS, Yang H, et al.Moutan Cortex and Paeoniae Radix Rubra reverse high-fat-diet-induced metabolic disorder and restore gut microbiota homeostasis. Chinese [J] Nat Med. 2017;15(3):210-219.

[[117]] Zhang Y, Gu Y, Ren H, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11(1):1-12.

[[118]] Apaydin S, Török M.Sulfonamide derivatives as multi-target agents for complex diseases. Bioorg Med Chem Lett. 2019;29(16):2042-2050.

[[119]] Wang X.Formation and development of serum pharmacochemistry of Chinese meterial medica. Modernization Traditional Chinese Med Materia Medica-World Sci Technol. 2010;12(4):632-633.

[[120]] Liang J, Xu F, Zhang YZ, et al. The profiling and identification of the absorbed constituents and metabolites of Paeoniae Radix Rubra decoction in rat plasma and urine by the HPLC-DAD-ESI-IT-TOF-MS(n) technique: a novel strategy for the systematic screening and identification of absorbed constituents and metabolites from traditional Chinese medicines. J Pharm Biomed Anal. 2013;83:108-121.

[[121]] Sun S, Zhu L, Hu Y, et al.Studies on the metabolism of paeoniflorin in human intestinal microflora by high performance liquid chromatography/electrospray ionization/Fourier transform ion cyclotron resonance mass spectrometry and quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1085:63-71.

[[122]] Shu YZ, Hattori M, Akao T, et al.Metabolism of paeoniflorin and related compounds by human intestinal bacteria. II. Structures of 7S- and 7R-paeonimetabolines I and II formed by Bacteroides fragilis and Lactobacillus brevis. Chem Pharm Bull (Tokyo). 1987;35(9):3726-3733.

[[123]] Wang Y, Zhao Z, Yan Y, et al.Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling. Int [J] Mol Sci. 2016;17(7):1036.

[[124]] Almazroo OA, Miah MK, Venkataramanan R.Drug metabolism in the liver. Clin Liver Dis. 2017;21(1):1-20.

[[125]] Miao WJ, Wang Q, Bo T, et al.Rapid characterization of chemical constituents and rats metabolites of the traditional Chinese patent medicine Gegen-Qinlian-Wan by UHPLC/DAD/qTOF-MS. [J] Pharm Biomed Anal. 2013;72:99-108.

[[126]] Yang N, Sun RB, Chen XL, et al.In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine. Acta Pharmacol Sin. 2017;38(3):351-361.

[[127]] Yang Y, Kang N, Xia H, et al.Metabolites of protoberberine alkaloids in human urine following oral administration of Coptidis Rhizoma decoction. Planta Med. 2010;76(16):1859-1863.

[[128]] Zuo F, Nakamura N, Akao T, et al.Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab Dispos. 2006;34(12):2064-2072.

[[129]] Song HB, Jiang Y, Liu JX, et al.Stimulation of osteogenic differentiation in bone marrow stromal cells via Wnt/β-catenin pathway by Qili Jiegu-containing serum. Biomed Pharmacother. 2018;103:1664-1668.

[[130]] Mao X, Hu Z, Wang Q, et al.Nitidine chloride is a mechanism-based inactivator of CYP2D6. Drug Metab Dispos. 2018;46(8):1137-1145.

[[131]] Li Y, Pan H, Li X, et al.Role of intestinal microbiota-mediated genipin dialdehyde intermediate formation in geniposide-induced hepatotoxicity in rats. Toxicol Appl Pharmacol. 2019;377:114624.

[[132]] Liu Y, Cui T, Peng Y, et al.Mechanism-based inactivation of cytochrome P450 2D6 by chelidonine. [J] Biochem Mol Toxicol. 2019;33(2):e22251.

[[133]] Lin D, Wang K, Guo X, et al.Lysine- and cysteine-based protein adductions derived from toxic metabolites of 8-epidiosbulbin E acetate. Toxicol Lett. 2016;264:20-28.

[[134]] Zhou S, Chan E, Duan W, et al.Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev. 2005;37(1):41-213.

[[135]] Yun BH, Rosenquist TA, Sidorenko V, et al.Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry. Chem Res Toxicol. 2012;25(5):1119-1131.

[[136]] Cui L, Sun E, Zhang ZH, et al.Enhancement of epimedium fried with suet oil based on in vivo formation of self-assembled flavonoid compound nanomicelles. Molecules (Basel, Switzerland). 2012;17(11):12984-12996.

[[137]] Jiang J, Li J, Zhang Z, et al.Mechanism of enhanced antiosteoporosis effect of circinal-icaritin by self-assembled nanomicelles in vivo with suet oil and sodium deoxycholate. Int [J] Nanomedicine. 2015;10:2377-2389.

[[138]] Ballabh P, Braun A, Nedergaard M.The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1-13.

[[139]] Mei J, Zhang B, Lu R.A preliminary attempt to develope the new cerebrospinal fluid pharmacology of Chinese Materia Medica on neurotrophic effects of astrocytes. Chinese Traditional and Herbal Drugs. 2000;31(7):523-526.

[[140]] Wu YQ, Zhou YW, Qin XD, et al.Cerebrospinal fluid pharmacology: an improved pharmacology approach for Chinese herbal medicine research. Evid Based Complement Alternat Med. 2013;2013:674305.

[[141]] Yu JB, Zhao ZX, Peng R, et al.Gut microbiota-based pharmacokinetics and the antidepressant mechanism of paeoniflorin. Front Pharmacol. 2019;10:268.

[[142]] Ho L, Ferruzzi MG, Janle EM, et al. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer’s disease. FASEB J. 2013;27(2):769-781.

[[143]] Mi N, Cheng T, Li H, et al.Metabolite profiling of traditional Chinese medicine formula Dan Zhi Tablet: An integrated strategy based on UPLC-QTOF/MS combined with multivariate statistical analysis. [J] Pharm Biomed Anal. 2019;164:70-85.

[[144]] Liang W, Xu W, Zhu J, et al.Ginkgo biloba extract improves brain uptake of ginsenosides by increasing blood-brain barrier permeability via activating A1 adenosine receptor signaling pathway. [J] Ethnopharmacol. 2020;246:112243.

[[145]] Yang Y-F, Xu W, Song W, et al.Transport of twelve coumarins from angelicae pubescentis radix across a MDCK-pHaMDR cell monolayer-An in vitro model for blood-brain barrier permeability. Molecules (Basel, Switzerland). 2015;20(7):11719-11732.

[[146]] Yu S, Fu L, Lu J, et al.Xiao-Yao-San reduces blood-brain barrier injury induced by chronic stress in vitro and vivo via glucocorticoid receptor-mediated upregulation of Occludin. [J] Ethnopharmacol. 2020;246:112165.

[[147]] Oddo A, Peng B, Tong Z, et al. Advances in microfluidic blood-brain barrier (BBB) models. Trends Biotechnol. 2019;37(12):1295-1314.

[[148]] Zhang X, Liu T, Fan X, et al.In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation. [J] Mol Graph Model. 2017;75:347-354.

[[149]] Maoz BM, Herland A, FitzGerald EA, et al. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells. Nat Biotechnol. 2018;36(9):865-874.

[[150]] Yáñez JA, Wang SWJ, Knemeyer IW, et al.Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev. 2011;63(10-11):923-942.

[[151]] Porter CJ, Charman WN.Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001;50(1-2):61-80.

[[152]] Wu H, Zhou A, Lu C, et al.Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems. Eur [J] Pharm Sci. 2011;42(4):348-353.

[[153]] Nakamura T, Kinjo C, Nakamura Y, et al.Lymphatic metabolites of quercetin after intestinal administration of quercetin-3-glucoside and its aglycone in rats. Arch Biochem Biophys. 2018;645:126-136.

[[154]] Wang J, Ma W, Tu P. The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: In vitro and in vivo. Colloids Surf B. 2015;133:108-119.

[[155]] Li F, Hu R, Wang B, et al. Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake. Acta Pharm Sin B. 2017;7(3):353-360.

[[156]] Trevaskis NL, Charman WN, Porter CJH.Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev. 2008;60(6):702-716.

[[157]] Zhang J, Wen X, Dai Y, et al.Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex. Int [J] Nanomedicine. 2019;14:7095-7106.

[[158]] Mattarei A, Rossa A, Bombardelli V, et al.Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue. Eur [J] Med Chem. 2017;135:77-88.